ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Tremfya 200 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung - 
69974001 Janssen-Cilag AG
Tremfya 200 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung10.06.2025
  10.06.2025
Guselkumab (L04AC16) 
WHO-DDD09.06.2030
 
07.15. 
B  
No 
IP 
PR  
k.A.PR
  
7680699740017Biotechnologika
  
Composition
guselkumabum 200 mg, histidinum, histidini hydrochloridum monohydricum, saccharum, polysorbatum 80, methioninum, dinatrii edetas corresp. natrium 0.05 mg, aqua ad iniectabile q.s. ad solutionem pro 20 ml.
Packungsbestandteile
Concentrate for infusion
 
 
Active AgentDose
Guselkumabum200mg / 20ml
 
Inactive agents
Dinatrii Edetas
Histidin Hydrochloride Monohydrate
Histidine
Methionine
Polysorbatum 80
Saccharum
Source
Data was imported : 11.07.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home